Litracen

Overview of the medication Litracen

Litracen
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Litracen is a pharmaceutical drug used primarily in the treatment of anxiety disorders and depression. It belongs to the class of medications known as antidepressants, specifically functioning as a serotonin-norepinephrine reuptake inhibitor (SNRI).

Mechanism of Action

Litracen works by inhibiting the reuptake of two key neurotransmitters in the brain: serotonin and norepinephrine. By preventing the reabsorption of these neurotransmitters, Litracen increases their availability in the synaptic cleft, thereby enhancing neurotransmission and improving mood and anxiety symptoms.

Indications

Litracen is indicated for the treatment of several conditions, including:

• Major depressive disorder
• Generalized anxiety disorder
• Panic disorder
• Social anxiety disorder

Dosage and Administration

Litracen is typically administered orally, with the dosage varying based on the specific condition being treated and the patient's response to the medication. It is important for patients to follow their healthcare provider's instructions regarding dosage and administration.

Side Effects

Common side effects of Litracen may include:

• Nausea
• Dizziness
• Dry mouth
• Insomnia
• Sweating

Serious side effects, though rare, can occur and may include:

• Hypertension
• Serotonin syndrome
• Suicidal thoughts

Contraindications

Litracen is contraindicated in patients with:

• Known hypersensitivity to Litracen or any of its components
• Concurrent use of monoamine oxidase inhibitors (MAOIs)

Interactions

Litracen can interact with several other medications, including:

• Monoamine oxidase inhibitors (MAOIs)
• Selective serotonin reuptake inhibitors (SSRIs)
• Tricyclic antidepressants (TCAs)

Pharmacokinetics

Litracen is well absorbed from the gastrointestinal tract and undergoes extensive hepatic metabolism. It has a half-life of approximately 12 hours, allowing for once or twice daily dosing.

History

Litracen was first developed in the late 20th century and received approval for medical use in several countries. It has since become a widely prescribed medication for the treatment of anxiety and depression.

Related pages

• Antidepressant
• Serotonin-norepinephrine reuptake inhibitor
• Anxiety disorder
• Depression (mood)

• 
  Litracen